Topic · Diet, Metabolism, and Disease
Most cited papers in Diet, Metabolism, and Disease
What are the most cited papers in Diet, Metabolism, and Disease?
The most cited paper in Diet, Metabolism, and Disease is "Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal" (Ndiaye, Matar, Lespez, Laurent, Tribolo, Chantal et al., 2024), with 24,104 citations. Next come "Harmonizing the Metabolic Syndrome" (14,957) and "Phosphorus Assay in Column Chromatography" (12,866).
Showing 50 of 98 papers. Every paper with more than 1,619 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal Ndiaye, Matar, Lespez, Laurent, Tribolo, Chantal et al. · Monash University Research Portal (Monash University) | 28 Mar 2024 | 24,104 |
| 2 | Harmonizing the Metabolic Syndrome K. G. M. M. Alberti, Robert H. Eckel, Scott M. Grundy et al. · Circulation | 5 Oct 2009 | 14,957 |
| 3 | Phosphorus Assay in Column Chromatography Grant R. Bartlett · Journal of Biological Chemistry | Mar 1959 | 12,866 |
| 4 | Role of Insulin Resistance in Human Disease Gerald M. Reaven · Diabetes | Dec 1988 | 12,183 |
| 5 | The metabolic syndrome—a new worldwide definition K. G. M. M. Alberti, Paul Zimmet, Jonathan Edward Shaw · The Lancet | Sep 2005 | 9,351 |
| 6 | Inflammation and metabolic disorders Gökhan S. Hotamışlıgil · Nature | 13 Dec 2006 | 9,214 |
| 7 | The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · Hepatology | 17 Jul 2017 | 7,419 |
| 8 | Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation K. G. M. M. Alberti, Paul Zimmet, Jonathan Edward Shaw · Diabetic Medicine | 20 Apr 2006 | 6,652 |
| 9 | The Thiobarbituric Acid Assay of Sialic Acids Leonard Warren · Journal of Biological Chemistry | Aug 1959 | 6,453 |
| 10 | The metabolic syndrome Robert H. Eckel, Scott M. Grundy, Paul Zimmet · The Lancet | Apr 2005 | 5,562 |
| 11 | Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Zobair M. Younossi, Quentin Mark Anstee, Milena Marietti et al. · Nature Reviews Gastroenterology & Hepatology | 20 Sep 2017 | 5,362 |
| 12 | Insulin signalling and the regulation of glucose and lipid metabolism Alan R. Saltiel, C. Ronald Kahn · Nature | Dec 2001 | 5,360 |
| 13 | Nonalcoholic Fatty Liver Disease Paul G. Angulo · New England Journal of Medicine | 18 Apr 2002 | 5,222 |
| 14 | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement Mohammed Eslam et al. · Journal of Hepatology | 8 Apr 2020 | 4,540 |
| 15 | Mechanisms of NAFLD development and therapeutic strategies Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary Eugenia Rinella et al. · Nature Medicine | 29 Jun 2018 | 4,390 |
| 16 | The Global Epidemic of the Metabolic Syndrome Mohammad G. Saklayen · Current Hypertension Reports | Feb 2018 | 4,129 |
| 17 | SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver Jay D. Horton, Joseph L. Goldstein, Michael Scott Brown · Journal of Clinical Investigation | May 2002 | 4,078 |
| 18 | Glycemic index of foods: a physiological basis for carbohydrate exchange David J.A. Jenkins, Thomas M. S. Wolever, R H Taylor et al. · American Journal of Clinical Nutrition | Mar 1981 | 3,872 |
| 19 | Obesity David William Haslam, W. P. T. James · The Lancet | Oct 2005 | 3,797 |
| 20 | Genistein, a specific inhibitor of tyrosine-specific protein kinases. Tetsu Akiyama, Junko Ishida, Shizue Nakagawa et al. · Journal of Biological Chemistry | Apr 1987 | 3,750 |
| 21 | Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Penny M. Kris‐Etherton, William Stephen Harris, Lawrence J. Appel · Circulation | 18 Nov 2002 | 3,714 |
| 22 | Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity Jeffrey D. Browning, Lidia S. Szczepaniak, Robert L. Dobbins et al. · Hepatology | 24 Nov 2004 | 3,698 |
| 23 | Coronary heart disease: seven dietary factors T. L. V. Ulbricht, D. A. T. Southgate · The Lancet | Oct 1991 | 3,644 |
| 24 | Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease Kerry L. Donnelly, Coleman I. Smith, Sarah Jane Schwarzenberg et al. · Journal of Clinical Investigation | 2 May 2005 | 3,526 |
| 25 | Mechanisms of fatty acid-induced inhibition of glucose uptake. G Boden, X Chen, J Ruiz et al. · Journal of Clinical Investigation | Jun 1994 | 3,479 |
| 26 | Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Stefano Romeo, Julia Kozlitina, Chao Xing et al. · Nature Genetics | 25 Sep 2008 | 3,462 |
| 27 | Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life Fredrik Bäckhed et al. · Cell Host & Microbe | May 2015 | 3,443 |
| 28 | MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease Mohammed Eslam et al. · Gastroenterology | 7 Feb 2020 | 3,358 |
| 29 | Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis Charles Nicholas Hales, David J.P. Barker · Diabetologia | Jul 1992 | 3,333 |
| 30 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary Eugenia Rinella et al. · Hepatology | 22 Jun 2023 | 3,191 |
| 31 | The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis · Metabolism | 4 Jan 2016 | 3,159 |
| 32 | NAFLD: A multisystem disease Christopher D. Byrne, Giovanni Targher · Journal of Hepatology | Apr 2015 | 3,158 |
| 33 | The Metabolic Syndrome and Cardiovascular Risk Salvatore Mottillo, Kristian B. Filion, Jacques J. Genest et al. · Journal of the American College of Cardiology | Sep 2010 | 3,061 |
| 34 | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Raphael Mechoulam, Shimon Ben‐Shabat, Lumir Ondrej Hanus et al. · Biochemical Pharmacology | Jun 1995 | 2,927 |
| 35 | The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Tomasz Szkudelski · Physiological Research | 2001 | 2,884 |
| 36 | Non-alcoholic fatty liver disease Elizabeth Ellen Powell, Vincent Wai‐Sun Wong, Mary Eugenia Rinella · The Lancet | 21 Apr 2021 | 2,840 |
| 37 | AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism Barbara B. Kahn, Thierry Alquier, David Carling et al. · Cell Metabolism | 2005 | 2,811 |
| 38 | Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas Paul E. Lacy, Mery Kostianovsky · Diabetes | 1967 | 2,779 |
| 39 | Quantitive estimation of sialic acids Lars Svennerholm · Biochimica et Biophysica Acta | 1957 | 2,770 |
| 40 | Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome Giulio Marchesini, Elisabetta Bugianesi, Gabriele Forlani et al. · Hepatology | Apr 2003 | 2,697 |
| 41 | PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE George J. Miller, N.E. Miller · The Lancet | 1975 | 2,639 |
| 42 | Human nutrition, the gut microbiome and the immune system Andrew L. Kau, Philip P. Ahern, Nicholas W. Griffin et al. · Nature | 14 Jun 2011 | 2,626 |
| 43 | Pathophysiology of Human Visceral Obesity: An Update André Tchernof, Jean‐Pierre Després · Physiological Reviews | 2013 | 2,612 |
| 44 | Nonalcoholic Fatty Liver Disease Giulio Marchesini, Mara Brizi, Giampaolo P. Bianchi et al. · Diabetes | Aug 2001 | 2,595 |
| 45 | Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis Herbert Tilg, Alexander Rupert Moschen · Hepatology | 20 Sep 2010 | 2,557 |
| 46 | AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease Mary Eugenia Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui et al. · Hepatology | 2 Feb 2023 | 2,541 |
| 47 | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Jorge Henao‐Mejia, Eran Elinav, Chengcheng Jin et al. · Nature | 31 Jan 2012 | 2,464 |
| 48 | Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis Geoffrey C. Farrell, Claire Z. Larter · Hepatology | 30 Jan 2006 | 2,433 |
| 49 | Origins and evolution of the Western diet: health implications for the 21st century1,2 Loren Cordain, S. Boyd Eaton, Anthony Sebastián et al. · American Journal of Clinical Nutrition | Feb 2005 | 2,411 |
| 50 | Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis David S. Ludwig, Karen E. Peterson, Steven L. Gortmaker · The Lancet | Feb 2001 | 2,411 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.